Skip to main content

Creative Planning

Position in EDIT — Editas Medicine, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in EDIT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$57,017
-$16,512 QoQ
Shares Held
23,084
+7.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Derivatives in EDIT

reported options exposure · as of Dec 31, 2020
CallValue
$35,055
CallShares
500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Creative Planning holds $360,319,340 across 212 Biotechnology names. EDIT ranks #192 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EDIT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $57,017 23,084
2024-09-30 $73,529 21,563
2024-06-30 $47,120 10,090
2022-03-31 $4,755 250
2021-06-30 $211,607 3,736
2021-03-31 $715,470 17,035
2020-12-31 $799,324 11,401
2020-12-31 $35,055 500
2020-09-30 $14,030 500
2020-09-30 $431,254 15,369
2020-06-30 $455,443 15,397
2020-03-31 $754,868 38,067